Erectile dysfunction in an urban HIV-positive population

AIDS Patient Care and STDs

Volumn 20, Issue 2, 2006, Pages 75-78

  Ende, Alexander R ^a   Lo Re III, Vincent ^b   DiNubile, Mark J ^c   Mounzer, Karam ^a,d  

^a Jonathan Lax Treatment Center   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Philadelphia FIGHT ^*

^d Philadelphia Fight   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TESTOSTERONE;

ADULT; AGED; ARTICLE; CD4 LYMPHOCYTE COUNT; DISASTER; DRUG USE; ERECTILE DYSFUNCTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERNATIONAL INDEX OF ERECTILE FUNCTION; MAJOR CLINICAL STUDY; MALE; OPPORTUNISTIC INFECTION; PREVALENCE; RATING SCALE; RISK FACTOR; TESTOSTERONE BLOOD LEVEL; UNITED STATES; URBAN AREA;

ADULT; AGED; CROSS-SECTIONAL STUDIES; HIV INFECTIONS; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; URBAN POPULATION;

EID: 33644504861     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.75     Document Type: Article

References (20)

1. Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rim EB. Sexual function in men older than 50 years of age: Results from the health professionals follow-up study. Ann Intern Med 2003;139:161-168.
2. Litwin MS, Nied RJ, Dhahani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998;13:159-166.
3. Laumann, EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999;281:537-544.
4. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Maderbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005;47:80-86.
5. Colson AE, Keller MJ, Sax PE, Pettus PT, Platt R, Choo PW. Male sexual dysfunction associated with antiretroviral therapy. J Acquir Immune Defic Syndr 2002;30:27-32.
6. Lallemand F, Salhi Y, Linard F, Giami A, Rozenbaum W. Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr 2002;30:187-190.
7. Schrooten W, Colebunbers R, Youle M, et al. Sexual dysfunction associated with protease inhibitors containing highly active antiretroviral treatment. AIDS 2001;15:1019-1023.
8. Cove J, Petrak J. Factors associated with sexual problems in HIV-positive gay men. Int J STD AIDS 2004;15:732-736.
9. Tindall B, Forde S, Goldstein D, Ross MW, Cooper, DA. Sexual dysfunction in advanced HIV disease. AIDS Care 1994;6:105-107.
10. Bancroft J, Carnes, L, Janssen, E. Unprotected anal intercourse in HIV positive and HIV negative gay men: The relevance of sexual arousability, mood, sensation seeking, and erectile problems. Arch Sex Behav 2005;34:299-305.
11. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirpatrick J, Mishra A. The international index of erectile function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-830.
12. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BN. Development and evaluation of an abridged, five-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:316-326.
13. Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both. Urology 2004;64:1196-1201.
14. Mota M, Lichiardopol C, Mota E, Panus C, Panus A. Erectile dysfunction in diabetes mellitus. Rom J Intern Med 2003;41:163-177.
15. Rosen RC, Marin H. Prevalence of antidepressant-associated erectile dysfunction. J Clin Psychiatry 2003;64(Suppl 10)5-10.
16. Rosen RC, Lane RM, Menza M. Effects of SSRIs on sexual function: A critical review. J Clin Psychopharmacol 1999;19:67-85.
17. Rhoden EL, Teloken C, Sogari PR, Vargas Souto CA. The use of the simplified international index of erectile function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res 2002;14:245-250.
18. Giuliano F, Chevret-Measson M, Tsatsaris A, Reitz C, Murino M, Thonneau P. Prevalence of erectile dysfunction in France: Results of an epidemiological survey of a representative sample of 1004 men. Eur Urol 2002;42:383-389.
19. Cachay E, Mar-Tang M, Matthews C. Screening for potentially transmitting sexual risk behaviors, urethral sexually transmitted infection, and sildenafil use among males entering care for HIV infection. AIDS Patient Care STDs 2004;18:349-354.
20. Giuliano F, Chevret-Measson M, Tsatsaris A, Reitz C, Murino M, Thonneau P. Prevalence of erectile dysfunction in France: Results of an epidemiological survey of a representative sample of 1004 men. Eur Urol 2002;42:383-389.